This biotech focuses on biologic therapies for immunological diseases, with lead candidates in nephrology and infectious ...

This biotechnology firm develops clinical-stage therapies for autoimmune and neuroinflammatory diseases using proprietary ...

ADMA Biologics develops plasma-derived therapies for immune deficiencies and infectious diseases, leveraging a vertically integrated model.

When chip giant Nvidia (NVDA) shows interest in any company, analysts and investors take note. According to Nvidia’s most ...

EPAM Systems (NYSE:EPAM) presented at the Bio-IT World Conference & Expo 2026, focusing on knowledge engineering and data advisory for biotech and life sciences. The company highlighted its role in ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

The shares of Q-Line Biotech IPO are commanding a strong premium in the grey market. According to Investorgain, the GMP of ...

Some things are inherently risky. Feeding a bear while camping and texting while driving come to mind. So does investing in biotech stocks. However, not every biotech stock is super-risky. Mirum ...

Biotechnology stocks are among the most high-risk, high-reward stocks in the market. Many biotech companies are working to ...

As Kevin Warsh steps up to lead the Federal Reserve, the case for interest-rate cuts is disappearing. Plus, investment newsletter commentary on AI”s circular ecosystem, emerging markets, and SpaceX.

CNS Pharmaceuticals (NASDAQ:CNSP) is back on every biotech watchlist after a 242.36% one-week ramp tied to its Berubicin ...